| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 744622 | 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide | 0.029334167004364 | 0.19890137 |
| NSC 750717 | 5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one | 0.0293341670043648 | 0.39978491 |
| NSC 752385 | Null | 0.0293341670043648 | 0.50282833 |
| NSC 751830 | 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one | 0.0295480456086945 | 0.101999 |
| NSC 102225 | Null | 0.0295480456086947 | 0.41658791 |
| NSC 132275 | Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) | 0.0295480456086947 | 0.2258684 |
| NSC 13275 | Null | 0.0295480456086947 | 0.43273429 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0295480456086947 | 0.37351436 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0295480456086947 | 0.1005254 |
| NSC 208885 | Null | 0.0295480456086947 | 0.13349843 |